Ane-Kristine Finbraten
Overview
Explore the profile of Ane-Kristine Finbraten including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Murphy S, Balzer N, Ranheim T, Sagen E, Huse C, Bjerkeli V, et al.
Front Immunol
. 2024 Jul;
15:1379570.
PMID: 38957465
There is a reciprocal relationship between extracellular matrix (ECM) remodelling and inflammation that could be operating in the progression of severe COVID-19. To explore the immune-driven ECM remodelling in COVID-19,...
2.
Malme K, Stene-Johansen K, Klundby I, Backe O, Foshaug T, Greve M, et al.
Viruses
. 2024 Jun;
16(6).
PMID: 38932151
Treatment of hepatitis C among people who inject drugs (PWID) may be complicated by loss to follow-up and reinfection. We aimed to evaluate sustained virologic response (SVR) and reinfection, and...
3.
Midgard H, Malme K, Finbraten A, Dalgard O
Clin Infect Dis
. 2024 Jun;
PMID: 38824443
No abstract available.
4.
Ueland T, Michelsen A, Tveita A, Kasine T, Dahl T, Finbraten A, et al.
Res Pract Thromb Haemost
. 2024 Jan;
8(1):102289.
PMID: 38292350
Background: Several studies have examined parameters of increased thrombogenicity in COVID-19, but studies examining their association with long-term outcome and potential effects of antiviral agents in hospitalized patients with COVID-19...
5.
Midgard H, Malme K, Pihl C, Berg-Pedersen R, Tanum L, Klundby I, et al.
Clin Infect Dis
. 2023 Nov;
78(3):582-590.
PMID: 37992203
Background: We aimed to evaluate the efficacy of opportunistic treatment of hepatitis C virus (HCV) infection among hospitalized people who inject drugs (PWID). Methods: We performed a pragmatic, stepped wedge...
6.
Malme K, Ulstein K, Finbraten A, Wusthoff L, Kielland K, Hauge J, et al.
Int J Drug Policy
. 2023 May;
116:104044.
PMID: 37149914
Background: Improving HCV treatment uptake among people who inject drugs (PWID) is crucial to achieving the WHO elimination targets. The aims were to evaluate HCV treatment uptake and HCV RNA...
7.
Finbraten A, Eckhardt B, Kapadia S, Marks K
Gastroenterol Hepatol (N Y)
. 2023 Mar;
18(11):628-638.
PMID: 36866028
The science for rapid treatment initiation for hepatitis C virus infection is in place. Easy and quick diagnostic tools can provide results within an hour. Necessary assessment before treatment initiation...
8.
Ueland T, Aikas L, Dahl T, Gregersen I, Olsen M, Michelsen A, et al.
J Infect
. 2023 Feb;
86(5):489-492.
PMID: 36822413
No abstract available.
9.
Leiva R, Bergersen B, Finbraten A, Sandvei P, Simonsen O, Rosseland C, et al.
Scand J Gastroenterol
. 2022 Sep;
58(3):264-268.
PMID: 36063075
Background And Aims: The recommended treatment duration of hepatitis C virus (HCV) genotype 1a (GT1a) infection with elbasvir/grazoprevir (EBR/GZR) in the presence of a high baseline viral load and resistance...
10.
Odegaard K, Finbraten A, Rudjord E, Falkenberg-Jensen B
Tidsskr Nor Laegeforen
. 2022 Aug;
142(11).
PMID: 35997192
Background: Calcific tendinitis of the longus colli muscle is an aseptic inflammatory reaction to calcium hydroxyapatite crystal deposition in the cervical prevertebral space. Case Presentation: A 40-year-old woman presented with...